PUBMED - Quality of life among older adults with HIV after switching to bictegravir-based three-drug or dolutegravir-based two-drug regimens
pubmed.ncbi.nlm.nih.gov/42751808
#produccionhuil #FatimaBranas #PabloRyan
pubmed.ncbi.nlm.nih.gov/42751808
#produccionhuil #FatimaBranas #PabloRyan
https://pubmed.ncbi.nlm.nih.gov/42751808/
pubmed.ncbi.nlm.nih.gov
September 21, 2026 at 12:00 PM
PUBMED - Quality of life among older adults with HIV after switching to bictegravir-based three-drug or dolutegravir-based two-drug regimens
pubmed.ncbi.nlm.nih.gov/42751808
#produccionhuil #FatimaBranas #PabloRyan
pubmed.ncbi.nlm.nih.gov/42751808
#produccionhuil #FatimaBranas #PabloRyan
PUBMED - Trends in HCV Infection Prevalence Among People with HIV in Spain Over Two Decades (2002-2023) pubmed.ncbi.nlm.nih.gov/40708503/ #produccionhuil #PabloRyan
Trends in HCV Infection Prevalence Among People with HIV in Spain Over Two Decades (2002-2023) - PubMed
HIV/HCV coinfection has drastically declined in Spain, with active HCV infection prevalence below 1% since 2021. DAAs were pivotal in this achievement. However, cirrhosis remains a concern among…
pubmed.ncbi.nlm.nih.gov
August 1, 2025 at 10:36 AM
PUBMED - Trends in HCV Infection Prevalence Among People with HIV in Spain Over Two Decades (2002-2023) pubmed.ncbi.nlm.nih.gov/40708503/ #produccionhuil #PabloRyan
PUBMED - IFNL4-rs12979860 CC genotype predisposes to accelerated terminal exhaustion and senescence in HIV/HCV-chronic infection pubmed.ncbi.nlm.nih.gov/41466297/
#produccionhuil #PabloRyan #MarianoMatarranz
#produccionhuil #PabloRyan #MarianoMatarranz
IFNL4-rs12979860 CC genotype predisposes to accelerated terminal exhaustion and senescence in HIV/HCV-chronic infection - PubMed
CC-carriage may result in premature cellular activation and senescence or impaired functionality during HCV chronic infection in PWH, which may be masked by their maintained plasma immune homeostasis…
pubmed.ncbi.nlm.nih.gov
January 7, 2026 at 10:01 AM
PUBMED - IFNL4-rs12979860 CC genotype predisposes to accelerated terminal exhaustion and senescence in HIV/HCV-chronic infection pubmed.ncbi.nlm.nih.gov/41466297/
#produccionhuil #PabloRyan #MarianoMatarranz
#produccionhuil #PabloRyan #MarianoMatarranz
Intravenous Administration of Remdesivir at the Acute Phase of SARS-CoV-2 Infection Is Associated with a Lower Prev… pubmed.ncbi.nlm.nih.gov/40364187/ #produccionhuil #remdesivir #covid #AnabelFrancoMoreno #PabloRyan #JuanTorresMacho
Intravenous Administration of Remdesivir at the Acute Phase of SARS-CoV-2 Infection Is Associated with a Lower Prevalence of Post-COVID-19 Pain - PubMed
<span><b>Background/Objective:</b> Evidence suggests that the administration of antivirals at the acute phase of SARS-CoV-2 infection is associated with lower COVID-19 severity, accordingly, the…
pubmed.ncbi.nlm.nih.gov
May 26, 2025 at 7:01 AM
Intravenous Administration of Remdesivir at the Acute Phase of SARS-CoV-2 Infection Is Associated with a Lower Prev… pubmed.ncbi.nlm.nih.gov/40364187/ #produccionhuil #remdesivir #covid #AnabelFrancoMoreno #PabloRyan #JuanTorresMacho
PUBMED - Clinical phenotypes and incidence of acute or recent hepatitis C virus infection and bacterial sexually transmitted infections among MSM with HIV
pubmed.ncbi.nlm.nih.gov/42682263/
#PabloRyan #produccionhuil
pubmed.ncbi.nlm.nih.gov/42682263/
#PabloRyan #produccionhuil
Clinical phenotypes and incidence of acute or recent hepatitis C virus infection and bacterial sexually transmitted infections among MSM with HIV - PubMed
Clinical phenotypes stratified ARHCV and bacterial STI incidence among MSM-HIV. ARHCV was concentrated in a small high-exposure subgroup, whereas bacterial STIs were more frequent in intermediate and high-exposure phenotypes. Phenotype-based approaches may help guide risk stratification and preventi …
pubmed.ncbi.nlm.nih.gov
September 2, 2026 at 12:05 PM
PUBMED - Clinical phenotypes and incidence of acute or recent hepatitis C virus infection and bacterial sexually transmitted infections among MSM with HIV
pubmed.ncbi.nlm.nih.gov/42682263/
#PabloRyan #produccionhuil
pubmed.ncbi.nlm.nih.gov/42682263/
#PabloRyan #produccionhuil
PUBMED - Advancing integration in the approach to older adults with HIV: perspectives from geriatric and HIV specialists pubmed.ncbi.nlm.nih.gov/41339812/ #produccionhuil #PabloRyan #FatimaBranas
Advancing integration in the approach to older adults with HIV: perspectives from geriatric and HIV specialists - PubMed
This study highlights significant gaps in knowledge, training, and interdisciplinary collaboration in the care of OAWH. While both geriatricians and HIV specialists recognize the unique needs of this…
pubmed.ncbi.nlm.nih.gov
December 19, 2025 at 8:01 AM
PUBMED - Advancing integration in the approach to older adults with HIV: perspectives from geriatric and HIV specialists pubmed.ncbi.nlm.nih.gov/41339812/ #produccionhuil #PabloRyan #FatimaBranas
PUBMED - Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022-2024) pubmed.ncbi.nlm.nih.gov/41311917/ #produccionhuil #PabloRyan
Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022-2024) - PubMed
MSM with prior HCV exposure had markedly higher HCV prevalence and incidence, regardless of HIV status. Risky sexual behaviors remain key drivers of HCV transmission. Behavior-informed prevention…
pubmed.ncbi.nlm.nih.gov
December 18, 2025 at 12:01 PM
PUBMED - Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022-2024) pubmed.ncbi.nlm.nih.gov/41311917/ #produccionhuil #PabloRyan
PUBMED - Hepatitis C elimination in people with HIV: progress, gaps, and future directions pubmed.ncbi.nlm.nih.gov/41311017/ #produccionhuil #PabloRyan
Hepatitis C elimination in people with HIV: progress, gaps, and future directions - PubMed
HCV elimination among PWH is feasible in well resourced settings, but global progress remains uneven. Universal screening, unrestricted DAA access, harm reduction, and sustained political commitment…
pubmed.ncbi.nlm.nih.gov
December 18, 2025 at 11:01 AM
PUBMED - Hepatitis C elimination in people with HIV: progress, gaps, and future directions pubmed.ncbi.nlm.nih.gov/41311017/ #produccionhuil #PabloRyan
PUBMED - Prognostic value of blood epigenetic biomarkers of aging in persons with well controlled HIV infection pubmed.ncbi.nlm.nih.gov/41024391/ #produccionhuil #PabloRyan
Prognostic value of blood epigenetic biomarkers of aging in persons with well controlled HIV infection - PubMed
In this preliminary study, GrimAge and PC-GrimAge were associated with increased risk of adverse outcomes in people with well-controlled HIV infection. These findings suggest their potential as…
pubmed.ncbi.nlm.nih.gov
October 3, 2025 at 12:01 PM
PUBMED - Prognostic value of blood epigenetic biomarkers of aging in persons with well controlled HIV infection pubmed.ncbi.nlm.nih.gov/41024391/ #produccionhuil #PabloRyan
PUBMED - Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial pubmed.ncbi.nlm.nih.gov/40982450/ #produccionhuil #PabloRyan
Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial - PubMed
BIC/FTC/TAF is an appropriate rapid initiation strategy in naïve PLHIV that improves their quality of life. It is pharmacoeconomically feasible and offers superior long-term health outcomes in compari...
pubmed.ncbi.nlm.nih.gov
September 23, 2025 at 9:16 AM
PUBMED - Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial pubmed.ncbi.nlm.nih.gov/40982450/ #produccionhuil #PabloRyan
PUBMED - Prevalence and risk factors of active hepatitis C infection among at-risk migrant populations in Madrid, Spain, 2019 to 2023 pubmed.ncbi.nlm.nih.gov/40709474/
#produccionhuil #PabloRyan #GuillermoCuevas #SamuelManzano #Samuel Estevez
#produccionhuil #PabloRyan #GuillermoCuevas #SamuelManzano #Samuel Estevez
Prevalence and risk factors of active hepatitis C infection among at-risk migrant populations in Madrid, Spain, 2019 to 2023 - PubMed
BACKGROUNDHepatitis C virus (HCV) microelimination among at-risk migrants supports global elimination goals.AIMTo evaluate risk factors, prevalence and trends of active HCV infection among at-risk…
pubmed.ncbi.nlm.nih.gov
August 1, 2025 at 10:37 AM
PUBMED - Prevalence and risk factors of active hepatitis C infection among at-risk migrant populations in Madrid, Spain, 2019 to 2023 pubmed.ncbi.nlm.nih.gov/40709474/
#produccionhuil #PabloRyan #GuillermoCuevas #SamuelManzano #Samuel Estevez
#produccionhuil #PabloRyan #GuillermoCuevas #SamuelManzano #Samuel Estevez
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide i… pubmed.ncbi.nlm.nih.gov/40489982/ #produccionhuil #HIV #PabloRyan #JuanTorresMacho
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-...
For the Spanish translation of the abstract see Supplementary Materials section.
pubmed.ncbi.nlm.nih.gov
June 10, 2025 at 9:40 AM
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide i… pubmed.ncbi.nlm.nih.gov/40489982/ #produccionhuil #HIV #PabloRyan #JuanTorresMacho
Antibody Response Against SARS-CoV-2 Spike Protein in People with HIV After COVID-19 Vaccination pubmed.ncbi.nlm.nih.gov/40432092/ #produccionhuil #PabloRyan #GuillermoCuevas #JorgeValencia #EvaJimenez #NataliaBlancaLopez #SamuelManzano #JuanIgnacioLazo #JuanTorresMacho
Antibody Response Against SARS-CoV-2 Spike Protein in People with HIV After COVID-19 Vaccination - PubMed
<span><b>Background/Objectives:</b> People with HIV (PWH) often have a suboptimal response to vaccines, raising concerns regarding the efficacy of coronavirus disease 2019 (COVID-19) vaccines in this…
pubmed.ncbi.nlm.nih.gov
May 29, 2025 at 8:01 AM
Antibody Response Against SARS-CoV-2 Spike Protein in People with HIV After COVID-19 Vaccination pubmed.ncbi.nlm.nih.gov/40432092/ #produccionhuil #PabloRyan #GuillermoCuevas #JorgeValencia #EvaJimenez #NataliaBlancaLopez #SamuelManzano #JuanIgnacioLazo #JuanTorresMacho